(Q37291341)

19 August 2017

1 reference

title

Antimicrobial-resistant Streptococcus pneumoniae: trends and management (English)

1 reference

19 August 2017

main subject

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

antimicrobial resistance

1 reference

Michael R Jacobs

1

1 reference

19 August 2017

publication date

1 October 2008

1 reference

Expert Review of Anti-infective Therapy

19 August 2017

published in

1 reference

19 August 2017

volume

6

1 reference

19 August 2017

issue

5

1 reference

19 August 2017

page(s)

619-635

1 reference

Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Genetic basis for the new pneumococcal serotype, 6C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Pneumococcal nasopharyngeal colonization in young South Indian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Active bacterial core surveillance of the emerging infections program network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Multinational study of pneumococcal serotypes causing acute otitis media in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Assessment of molecular typing methods to determine invasiveness and to differentiate clones of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Treatment of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Trends in antimicrobial drug prescribing among office-based physicians in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Mechanisms of resistance among respiratory tract pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Diagnosis and management of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Antimicrobial resistance among pediatric respiratory tract infections: clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Trends in otitis media treatment failure and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Serotype prevalence of occult pneumococcal bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Practice guidelines for the management of bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Impact of conjugate pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Stretching the mutant prevention concentration (MPC) beyond its limits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

The presence of the tetO gene in a variety of tetracycline-resistant Streptococcus pneumoniae serotypes from Washington State

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Antibiotic treatment in acute Otitis Media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Bacterial eradication in the treatment of otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Emergence of Multiply Resistant Pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Streptococcus pneumoniae resistant to penicillin and chloramphenicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Activity of doripenem and comparator beta-lactams against US clinical isolates of Streptococcus pneumoniae with defined mutations in the penicillin-binding domains of pbp1a, pbp2b and pbp2x

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Moxifloxacin: a review of its use in the management of bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

In vitro activity of the new quinolone WCK 771 against staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Teicoplanin or vancomycin in the treatment of gram-positive infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

In vitro activity of ertapenem against selected respiratory pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Serotype 19A Variants of the Spanish Serotype 23F Multiresistant Clone of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.5.619

21 January 2018

Identifiers

DOI

10.1586/14787210.6.5.619

1 reference

19 August 2017

1 reference